Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
2.110
0.00 (0.00%)
Nov 14, 2025, 10:37 AM EST
Nuo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.51 | 0.28 | 0.93 | 2.05 | 1.41 | 0.16 | Upgrade |
Cash & Short-Term Investments | 0.51 | 0.28 | 0.93 | 2.05 | 1.41 | 0.16 | Upgrade |
Cash Growth | -24.72% | -69.45% | -54.73% | 45.01% | 776.26% | -32.81% | Upgrade |
Accounts Receivable | 0.65 | 0.25 | 0.25 | 0.09 | - | - | Upgrade |
Receivables | 0.65 | 0.25 | 0.25 | 0.09 | - | - | Upgrade |
Inventory | 0.2 | 0.15 | 0.21 | 0.24 | - | - | Upgrade |
Prepaid Expenses | 0.09 | 0.16 | 0.17 | 0.2 | 0.05 | - | Upgrade |
Restricted Cash | - | - | - | 0.06 | - | - | Upgrade |
Total Current Assets | 1.46 | 0.84 | 1.56 | 2.63 | 1.47 | 0.16 | Upgrade |
Property, Plant & Equipment | 0.46 | 0.35 | 0.31 | 0.41 | - | - | Upgrade |
Total Assets | 1.93 | 1.19 | 1.88 | 3.05 | 1.47 | 0.16 | Upgrade |
Accounts Payable | 0.49 | 0.22 | 0.39 | 0.4 | 0.53 | 0.52 | Upgrade |
Accrued Expenses | 0.39 | 0.29 | 0.19 | 0.12 | 0.15 | 0.15 | Upgrade |
Current Portion of Leases | 0.07 | 0.07 | 0.09 | 0.08 | - | - | Upgrade |
Current Unearned Revenue | 0.3 | - | - | - | - | - | Upgrade |
Total Current Liabilities | 1.26 | 0.58 | 0.67 | 0.6 | 0.67 | 0.66 | Upgrade |
Long-Term Leases | 0.04 | 0.1 | 0.16 | 0.26 | - | - | Upgrade |
Long-Term Unearned Revenue | 1.05 | - | - | - | - | - | Upgrade |
Other Long-Term Liabilities | - | - | - | -0 | - | - | Upgrade |
Total Liabilities | 2.35 | 0.68 | 0.84 | 0.86 | 0.67 | 0.66 | Upgrade |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Additional Paid-In Capital | 33.77 | 32.77 | 30.97 | 28.95 | 24.38 | 23 | Upgrade |
Retained Earnings | -34.19 | -32.26 | -29.94 | -26.76 | -23.59 | -23.5 | Upgrade |
Total Common Equity | -0.42 | 0.51 | 1.04 | 2.19 | 0.79 | -0.5 | Upgrade |
Shareholders' Equity | -0.42 | 0.51 | 1.04 | 2.19 | 0.79 | -0.5 | Upgrade |
Total Liabilities & Equity | 1.93 | 1.19 | 1.88 | 3.05 | 1.47 | 0.16 | Upgrade |
Total Debt | 0.11 | 0.16 | 0.26 | 0.34 | - | - | Upgrade |
Net Cash (Debt) | 0.4 | 0.12 | 0.67 | 1.72 | 1.41 | 0.16 | Upgrade |
Net Cash Growth | -20.70% | -82.25% | -60.78% | 21.32% | 776.26% | - | Upgrade |
Net Cash Per Share | 0.01 | 0.00 | 0.02 | 0.04 | 0.05 | 0.01 | Upgrade |
Filing Date Shares Outstanding | 48.08 | 46.82 | 44.24 | 41.8 | 37.12 | 25.69 | Upgrade |
Total Common Shares Outstanding | 47.88 | 46.82 | 44.24 | 41.8 | 37.12 | 25.69 | Upgrade |
Working Capital | 0.21 | 0.26 | 0.89 | 2.03 | 0.79 | -0.5 | Upgrade |
Book Value Per Share | -0.01 | 0.01 | 0.02 | 0.05 | 0.02 | -0.02 | Upgrade |
Tangible Book Value | -0.42 | 0.51 | 1.04 | 2.19 | 0.79 | -0.5 | Upgrade |
Tangible Book Value Per Share | -0.01 | 0.01 | 0.02 | 0.05 | 0.02 | -0.02 | Upgrade |
Machinery | 0.84 | 0.61 | 0.45 | 0.45 | 0.39 | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.